Global Tissue Banking Market Insights, Size, and Forecast By End Use (Hospitals, Research Institutes, Biotechnology Companies), By Type of Tissue (Muscle Tissue, Nerve Tissue, Connective Tissue, Epithelial Tissue), By Application (Research, Transplantation, Therapeutic), By Process Type (Collection, Processing, Storage, Distribution), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035
Key Market Insights
Global Tissue Banking Market is projected to grow from USD 4.1 Billion in 2025 to USD 9.8 Billion by 2035, reflecting a compound annual growth rate of 9.6% from 2026 through 2035. The tissue banking market encompasses the collection, processing, storage, and distribution of human tissues for therapeutic, research, and diagnostic purposes. This vital industry underpins various medical advancements, providing critical biological materials for transplantation, regenerative medicine, and drug discovery. The market is primarily driven by the escalating prevalence of chronic diseases requiring tissue replacement, such as cardiovascular diseases, orthopedic conditions, and organ failures. Advancements in biotechnology and preservation techniques, leading to improved tissue viability and functionality, further fuel market expansion. The increasing awareness and acceptance of organ and tissue donation, coupled with a growing elderly population prone to age-related tissue degeneration, also contribute significantly to market growth. However, the market faces restraints such as ethical concerns surrounding tissue procurement, stringent regulatory frameworks that can slow innovation, and the high cost associated with tissue processing and storage. The leading segment, transplantation, holds the largest share due to the ongoing need for tissues in surgical procedures and organ replacement therapies.
Global Tissue Banking Market Value (USD Billion) Analysis, 2025-2035
2025 - 2035
www.makdatainsights.com
Important market trends include the rising adoption of automated tissue banking systems for enhanced efficiency and reduced human error, the growing emphasis on personalized medicine which necessitates a diverse range of tissue samples, and the emergence of advanced biobanking technologies like cryopreservation and vitrification. Opportunities abound in the development of novel tissue engineering techniques, the expansion into emerging economies with underserved healthcare needs, and strategic collaborations between academic institutions, research organizations, and commercial entities to accelerate tissue-based research and product development. North America dominates the global market, primarily due to its well-established healthcare infrastructure, high research and development expenditure, and the presence of numerous key market players. The region benefits from robust government support for tissue banking initiatives and a strong culture of organ and tissue donation.
Asia Pacific is anticipated to be the fastest growing region, propelled by improving healthcare infrastructure, increasing disposable incomes, a large patient pool, and rising medical tourism. Governments in this region are also increasingly investing in healthcare, including tissue banking facilities, to address the growing demand for advanced medical treatments. Key players in this competitive landscape include Regenative Labs, Acell, Stemcell Technologies, Global Stem Cells Group, Cureline, Tissue Regeneration, Organogenesis, Biolife Solutions, Harvard Bioscience, and Lonza. These companies are employing various strategies such as mergers and acquisitions to expand their product portfolios and geographical reach, focusing on technological advancements to improve tissue preservation and processing, and forging strategic partnerships to enhance research capabilities and market penetration. Their efforts are directed towards meeting the evolving demands of the healthcare sector and solidifying their positions in the global tissue banking market.
Quick Stats
Market Size (2025):
USD 4.1 BillionProjected Market Size (2035):
USD 9.8 BillionLeading Segment:
Transplantation (45.8% Share)Dominant Region (2025):
North America (38.7% Share)CAGR (2026-2035):
9.6%
What is Tissue Banking?
Tissue banking involves the collection, processing, storage, and distribution of human tissues for therapeutic and research purposes. It is a critical component of modern medicine, providing essential biological materials like bone, skin, heart valves, and corneas. Tissues are meticulously screened for diseases, preserved to maintain viability and integrity, and stored in controlled environments, often cryogenic, until needed. This process ensures the availability of safe and effective allografts for reconstructive surgery, transplantation, and other medical applications. Tissue banking plays a vital role in patient care, disease treatment, and advancing scientific understanding, offering renewed hope and improved quality of life.
What are the Trends in Global Tissue Banking Market
AI Driven Cryopreservation Innovations
Decentralized Biobanking Network Expansion
Next Generation Organoid Banking Advances
Ethical Sourcing Transparency imperative
Personalized Regenerative Medicine Integration
AI Driven Cryopreservation Innovations
AI driven cryopreservation innovations are revolutionizing tissue banking by optimizing the entire preservation process. Machine learning algorithms analyze vast datasets of cell types, cryoprotectant formulations, cooling rates, and thawing protocols to predict optimal conditions for maximum cell viability and functionality. This trend enables personalized cryopreservation strategies for diverse tissues and organs, minimizing cellular damage and improving post thaw recovery. AI models can identify critical parameters influencing successful long term storage, leading to smarter, more efficient cryopreservation devices and protocols. Ultimately, these innovations enhance the quality and reliability of banked tissues, expanding their utility in research, regenerative medicine, and transplantation, while also addressing current challenges in sample degradation and ethical considerations around limited viability.
Decentralized Biobanking Network Expansion
Decentralized biobanking networks are rapidly expanding within the global tissue banking market, driven by the need for enhanced research collaboration and improved sample accessibility. This trend involves establishing multiple interconnected smaller biobanks rather than relying on a few large centralized facilities. Researchers benefit from distributed collections of diverse, high quality biospecimens, allowing for broader study participation and reducing logistical hurdles often associated with single site repositories.
The shift promotes greater data sharing among institutions and facilitates the development of federated research projects. It also addresses concerns about single point failure risks and enables more localized ethical and regulatory oversight. Technological advancements in sample tracking and secure data management underpin this expansion, ensuring sample integrity and patient privacy across the distributed network, ultimately accelerating biomedical discovery.
What are the Key Drivers Shaping the Global Tissue Banking Market
Rising Demand for Regenerative Medicine & Cell Therapies
Advancements in Tissue Engineering & Preservation Technologies
Increasing Incidence of Chronic Diseases & Organ Failure
Growing Investment in Healthcare Infrastructure & R&D
Expansion of Personalized Medicine & Biobanking Initiatives
Rising Demand for Regenerative Medicine & Cell Therapies
The escalating demand for regenerative medicine and cell therapies is a pivotal driver in the global tissue banking market. As scientific advancements yield innovative treatments for a myriad of diseases, the need for high-quality, ethically sourced biological materials intensifies. Regenerative therapies, including stem cell treatments, gene therapies, and tissue engineering solutions, rely heavily on accessible banks of human tissues, cells, and other biomaterials for research, development, and ultimately, clinical application. This burgeoning field addresses conditions ranging from chronic diseases and organ failure to trauma and neurological disorders, creating a sustained and growing requirement for a robust tissue banking infrastructure. The continued promise of these cutting-edge medical interventions directly translates into increased utilization and expansion of tissue banking services worldwide.
Advancements in Tissue Engineering & Preservation Technologies
Innovations in tissue engineering and preservation are fundamentally transforming global tissue banking. Breakthroughs in stem cell research, biomaterials, and regenerative medicine enable the creation and successful storage of more complex and functional tissues. Advanced cryopreservation techniques, including vitrification and novel cryoprotectants, significantly improve tissue viability and reduce damage during freezing and thawing. This minimizes cell death, preserves tissue integrity, and extends storage durations, making a wider range of tissues available for transplantation and research. These technological leaps are expanding the types of tissues that can be banked, enhancing their quality, and increasing their utility in clinical applications, thereby fueling substantial market growth.
Increasing Incidence of Chronic Diseases & Organ Failure
A growing global population coupled with longer lifespans contributes significantly to the rising prevalence of chronic conditions such as diabetes, heart disease, cancer, and neurodegenerative disorders. These diseases often lead to irreversible damage to various organs, necessitating transplants or regenerative therapies. Organ failure, stemming from both acute injuries and the progression of these chronic ailments, creates an urgent and sustained demand for healthy, banked tissues and organs for transplantation. Consequently, tissue banks become crucial repositories for materials like corneas, skin, bone, and cardiovascular tissues, directly addressing the increasing need for treatments and life saving interventions driven by this rising burden of chronic disease and organ failure.
Global Tissue Banking Market Restraints
Lack of Standardized Protocols and Regulations Hindering Global Expansion
The absence of universally accepted protocols and consistent regulatory frameworks poses a significant challenge to the global tissue banking market’s expansion. Diverse national guidelines regarding tissue procurement, processing, storage, and distribution create complex hurdles for organizations aiming to operate across borders. This lack of standardization complicates the transfer of tissues between countries, restricts the establishment of international collaborations, and increases operational costs due to the need to comply with multiple, often conflicting, legal and ethical requirements. Harmonizing these varied regulations is crucial. Without a unified approach, tissue banks face immense difficulties in ensuring the quality and safety of tissues globally, impeding the market's potential to provide life saving allografts to patients worldwide and hindering its further development.
High Operational Costs and Limited Funding for Tissue Banking Infrastructure
High operational costs present a significant restraint in the global tissue banking market. Establishing and maintaining tissue banks demands substantial financial investment, encompassing specialized equipment, skilled personnel, and stringent quality control measures. These costs are exacerbated by the need for advanced preservation techniques, sterile environments, and regulatory compliance. Many organizations, particularly in developing regions, struggle to secure adequate funding to meet these demanding financial requirements. Limited public and private sector funding restricts the expansion of existing tissue banks and the establishment of new facilities. This financial barrier directly impacts the accessibility and availability of banked tissues, hindering market growth. The ongoing expenses for infrastructure maintenance, quality assurance, and staff training create a continuous financial strain, limiting the capacity to invest in innovation and expand service offerings.
Global Tissue Banking Market Opportunities
Capitalizing on the Escalating Demand for Regenerative Medicine and Personalized Therapy Tissues
The global tissue banking market offers a prime opportunity to capitalize on the escalating demand for regenerative medicine and personalized therapy tissues. As medical science advances, there is a critical need for specialized biological materials to support innovative treatments, organ repair, and individualized patient therapies. Tissue banks can strategically position themselves as essential providers by enhancing capabilities in sourcing, processing, and storing these highly specific tissues. This involves investing in advanced cryopreservation techniques, ensuring stringent quality control, and expanding robust donor networks. Particularly in rapidly growing healthcare markets like Asia Pacific, there is immense potential to establish state of the art facilities and comprehensive supply chains. By focusing on ethical procurement, maintaining high standards for tissue viability, and developing efficient distribution channels, tissue banks can meet this increasing global requirement. This approach fosters innovation in therapeutic applications, improves patient outcomes, and secures a pivotal role for tissue banking in the future of healthcare delivery.
Driving Operational Efficiency and Quality Control with AI and Automation in Tissue Banking
The global tissue banking market presents a significant opportunity to integrate AI and automation for unparalleled operational efficiency and quality control, particularly in rapidly expanding regions like Asia Pacific. This advancement transforms tissue banking from donor screening to distribution.
AI enhances donor suitability assessment through sophisticated data analytics, identifying risks with greater precision and speed. Automation streamlines complex tissue processing, ensuring consistent quality, minimizing human error, and accelerating throughput. Robotics can manage repetitive tasks like sample handling and storage, reducing labor costs and improving facility utilization. Real time AI driven monitoring systems provide continuous quality checks, ensuring compliance with stringent safety regulations. This holistic integration optimizes inventory management, reduces waste, and boosts overall productivity. Ultimately, AI and automation deliver safer, higher quality tissues, enhancing traceability and improving patient outcomes across the globe.
Global Tissue Banking Market Segmentation Analysis
Key Market Segments
By Application
- •Research
- •Transplantation
- •Therapeutic
By Type of Tissue
- •Muscle Tissue
- •Nerve Tissue
- •Connective Tissue
- •Epithelial Tissue
By Process Type
- •Collection
- •Processing
- •Storage
- •Distribution
By End Use
- •Hospitals
- •Research Institutes
- •Biotechnology Companies
Segment Share By Application
Share, By Application, 2025 (%)
- Transplantation
- Research
- Therapeutic
www.makdatainsights.com
Why is Transplantation the leading application segment in the Global Tissue Banking Market?
Transplantation commands the largest share due to the immediate and critical demand for viable tissues in life saving medical procedures and reconstructive surgeries. Tissues such as bone, skin, corneas, and heart valves are extensively banked to address organ and tissue failure, severe trauma, and chronic diseases. The established clinical pathways, increasing prevalence of conditions necessitating transplants, and a growing aging global population directly fuel this segment's dominance, overshadowing research and therapeutic applications which, while vital, have different scales of clinical urgency and market maturity.
What factors contribute to the significant market share of Connective Tissue within the tissue type segmentation?
Connective tissue, encompassing bone, cartilage, tendons, and ligaments, holds a substantial share primarily because of its widespread utility in transplantation procedures. Injuries, degenerative diseases, and trauma frequently necessitate the grafting of bone and other connective tissues for reconstruction, repair, and regeneration. Its critical role in orthopedic surgeries, dental applications, and plastic surgery ensures a consistently high demand compared to other tissue types like muscle or nerve tissue, which have more specialized or emerging applications.
How do End Use segments contribute to the comprehensive ecosystem of tissue banking operations?
Hospitals represent a primary end use, acting as major consumers for banked tissues in direct patient care, particularly for transplantation and surgical repair. Research Institutes are crucial for advancing tissue engineering, disease modeling, and understanding tissue biology, driving future innovations. Biotechnology Companies contribute significantly by developing novel tissue processing methods, preservation techniques, and often provide the infrastructure for large scale tissue collection, processing, and distribution, thus forming an interconnected network essential for the market's overall functionality and growth.
What Regulatory and Policy Factors Shape the Global Tissue Banking Market
The global tissue banking market navigates a complex, fragmented regulatory environment. Key regions including North America, Europe, and Asia Pacific maintain distinct frameworks, yet show a trend towards harmonization. In the United States, the FDA’s Human Cells, Tissues, and Cellular and Tissue Based Products HCT P regulations rigorously govern donor eligibility, procurement, processing, storage, and distribution, prioritizing patient safety and product quality. European Union member states adhere to comprehensive EU Tissues and Cells Directives 2004 23 EC, 2006 17 EC, and 2006 86 EC. These directives establish stringent quality and safety standards for human tissues and cells for human application, encompassing donor selection, testing, and operational accreditation of tissue establishments. Globally, ethical considerations surrounding informed consent, traceability, and data privacy are paramount, leading to robust national legislation. Emerging technologies like gene editing and regenerative medicine introduce new regulatory challenges, pushing authorities to adapt existing guidelines and develop novel frameworks to ensure innovation occurs safely and ethically across diverse jurisdictions.
What New Technologies are Shaping Global Tissue Banking Market?
The Global Tissue Banking Market is significantly shaped by groundbreaking innovations. Advanced cryopreservation techniques, including vitrification, are revolutionizing tissue viability and long term storage, minimizing ice crystal formation and improving post thaw functionality. Automation and robotics streamline tissue processing, cataloging, and retrieval, boosting operational efficiency and reducing human error. This technological leap enhances throughput and ensures standardized handling across large tissue repositories.
Emerging digital solutions, such as sophisticated biobanking informatics platforms and artificial intelligence, are transforming data management. They enable more precise donor recipient matching, improve inventory tracking, and facilitate complex research analytics, thereby accelerating scientific discovery. Furthermore, integration with regenerative medicine advancements, including tissue engineering and 3D bioprinting, is broadening the scope and demand for specialized tissue types, driving market expansion and new collection protocols. Enhanced quality control measures and advanced pathogen detection systems further bolster safety and trust.
Global Tissue Banking Market Regional Analysis
Global Tissue Banking Market
Trends, by Region
North America Market
Revenue Share, 2025
www.makdatainsights.com
Dominant Region
North America · 38.7% share
North America dominated the global tissue banking market, securing a substantial 38.7% revenue share. This prominent position is attributed to several key factors. The region boasts a highly advanced healthcare infrastructure, facilitating the establishment and operation of sophisticated tissue banks. Furthermore, significant investments in research and development, particularly in regenerative medicine and cell therapies, are propelling market expansion. A well-established regulatory framework and favorable reimbursement policies also contribute to market maturity and accessibility. High awareness among both medical professionals and the general public regarding the benefits of tissue donation and transplantation further strengthens North America's leadership in this vital sector.
Fastest Growing Region
Asia Pacific · 13.2% CAGR
Asia Pacific is poised to emerge as the fastest growing region in the global tissue banking market, exhibiting a robust Compound Annual Growth Rate CAGR of 13.2% from 2026 to 2035. This accelerated expansion is fueled by several key factors. A rapidly aging population within countries like China and India drives an increased demand for regenerative medicine and tissue transplants. Simultaneously, rising healthcare expenditure and improving medical infrastructure across the region facilitate greater access to advanced treatment options including tissue banking services. Furthermore, a growing awareness regarding the benefits of tissue donation and the establishment of more sophisticated tissue banks contribute significantly to this remarkable growth trajectory. Economic development and government initiatives supporting healthcare innovation further solidify Asia Pacific's leading position.
Top Countries Overview
The U.S. leads the global tissue banking market, driven by advanced infrastructure and a robust regulatory framework. High demand for transplantable tissues, particularly musculoskeletal and skin grafts, fuels growth. Technological advancements in tissue processing and storage further strengthen its position, with significant investment in research and development to expand applications and improve graft viability.
China is a significant player in the global tissue banking market, experiencing rapid growth driven by rising healthcare needs and improved infrastructure. While regulatory frameworks are still developing, increasing investment in research and development, particularly in areas like stem cell banking, positions China for continued expansion. Its large population offers a substantial potential donor pool, attracting international partnerships and fostering domestic advancements in tissue engineering and regenerative medicine.
India's a growing player in global tissue banking, driven by increasing healthcare awareness, rising incomes, and a large patient pool. Challenges include regulatory standardization and infrastructure development. However, its potential for affordable, high-quality tissue processing and storage, coupled with medical tourism, positions India for significant future expansion in the international tissue banking landscape, especially for bone, skin, and cord blood.
Impact of Geopolitical and Macroeconomic Factors
Geopolitically, increasing global conflicts and natural disasters drive demand for tissue banking, particularly allografts for trauma and reconstruction. Refugee crises and mass casualty events strain existing infrastructure, necessitating robust international supply chains. However, political instability in key donor or processing regions could disrupt supply, while rising nationalism might hinder cross border tissue sharing. Ethical considerations surrounding tissue procurement in politically sensitive areas also pose challenges, influencing market acceptance and regulatory frameworks globally. Evolving international guidelines for tissue exchange and transplantation will shape market access and competitive landscapes.
Macroeconomically, aging populations in developed nations are fueling demand for regenerative medicine and reconstructive procedures, directly impacting tissue banking growth. Healthcare spending patterns, influenced by economic recessions or expansions, dictate public and private investment in these technologies. Inflationary pressures on operational costs, including processing and storage, could impact profitability. Currency fluctuations affect the affordability of imported tissues and technology, while the increasing prevalence of medical tourism for advanced treatments can create regional hubs for tissue banking services.
Recent Developments
- March 2025
Regenative Labs announced a strategic partnership with Global Stem Cells Group to expand their reach in regenerative medicine. This collaboration aims to develop standardized protocols for tissue collection and processing, enhancing market trust and efficiency.
- July 2024
Acell acquired a significant stake in Tissue Regeneration, a move aimed at bolstering its capabilities in advanced wound care and reconstructive therapies. This acquisition is expected to integrate Acell's proprietary ECM technology with Tissue Regeneration's extensive tissue bank resources.
- November 2024
Lonza launched a new line of cryopreservation solutions specifically optimized for diverse tissue types, including musculoskeletal and cardiovascular tissues. These new solutions are designed to improve post-thaw viability and functionality, addressing critical needs in the global tissue banking market.
- February 2025
Harvard Bioscience, through its subsidiary specializing in laboratory automation, introduced a fully automated tissue processing and banking system. This system aims to significantly reduce manual labor, minimize contamination risks, and improve throughput for large-scale tissue banking operations.
- September 2024
Stemcell Technologies announced a partnership with Cureline to provide integrated solutions for cancer research, focusing on sourcing and processing patient-derived xenografts (PDX) and organoids. This collaboration will accelerate drug discovery and development by ensuring access to high-quality, characterized human tissue models.
Key Players Analysis
Key players in the global tissue banking market include Regenative Labs and Acell focusing on regenerative medicine and advanced wound care using stem cell and extracellular matrix technologies. Stemcell Technologies and Lonza are crucial suppliers of specialized media and reagents supporting research and clinical applications. Global Stem Cells Group emphasizes stem cell banking and therapies. Cureline provides biobanking services, contributing to research and diagnostics. Organogenesis and Tissue Regeneration are active in developing regenerative tissue products. Biolife Solutions and Harvard Bioscience offer essential cold chain management and laboratory equipment, respectively. These companies are strategically expanding through partnerships and R&D investments, driving market growth through innovative therapies and improved preservation techniques.
List of Key Companies:
- Regenative Labs
- Acell
- Stemcell Technologies
- Global Stem Cells Group
- Cureline
- Tissue Regeneration
- Organogenesis
- Biolife Solutions
- Harvard Bioscience
- Lonza
- Medtronic
- Fresenius Kabi
Report Scope and Segmentation
| Report Component | Description |
|---|---|
| Market Size (2025) | USD 4.1 Billion |
| Forecast Value (2035) | USD 9.8 Billion |
| CAGR (2026-2035) | 9.6% |
| Base Year | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2035 |
| Segments Covered |
|
| Regional Analysis |
|
Table of Contents:
List of Figures
List of Tables
Table 1: Global Tissue Banking Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 2: Global Tissue Banking Market Revenue (USD billion) Forecast, by Type of Tissue, 2020-2035
Table 3: Global Tissue Banking Market Revenue (USD billion) Forecast, by Process Type, 2020-2035
Table 4: Global Tissue Banking Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 5: Global Tissue Banking Market Revenue (USD billion) Forecast, by Region, 2020-2035
Table 6: North America Tissue Banking Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 7: North America Tissue Banking Market Revenue (USD billion) Forecast, by Type of Tissue, 2020-2035
Table 8: North America Tissue Banking Market Revenue (USD billion) Forecast, by Process Type, 2020-2035
Table 9: North America Tissue Banking Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 10: North America Tissue Banking Market Revenue (USD billion) Forecast, by Country, 2020-2035
Table 11: Europe Tissue Banking Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 12: Europe Tissue Banking Market Revenue (USD billion) Forecast, by Type of Tissue, 2020-2035
Table 13: Europe Tissue Banking Market Revenue (USD billion) Forecast, by Process Type, 2020-2035
Table 14: Europe Tissue Banking Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 15: Europe Tissue Banking Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 16: Asia Pacific Tissue Banking Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 17: Asia Pacific Tissue Banking Market Revenue (USD billion) Forecast, by Type of Tissue, 2020-2035
Table 18: Asia Pacific Tissue Banking Market Revenue (USD billion) Forecast, by Process Type, 2020-2035
Table 19: Asia Pacific Tissue Banking Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 20: Asia Pacific Tissue Banking Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 21: Latin America Tissue Banking Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 22: Latin America Tissue Banking Market Revenue (USD billion) Forecast, by Type of Tissue, 2020-2035
Table 23: Latin America Tissue Banking Market Revenue (USD billion) Forecast, by Process Type, 2020-2035
Table 24: Latin America Tissue Banking Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 25: Latin America Tissue Banking Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 26: Middle East & Africa Tissue Banking Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 27: Middle East & Africa Tissue Banking Market Revenue (USD billion) Forecast, by Type of Tissue, 2020-2035
Table 28: Middle East & Africa Tissue Banking Market Revenue (USD billion) Forecast, by Process Type, 2020-2035
Table 29: Middle East & Africa Tissue Banking Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 30: Middle East & Africa Tissue Banking Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035